Search results
Jacobs Solutions Q3 Earnings Call Highlights
Key Points
- Interested in Jacobs Solutions Inc.? Here are five stocks we like better.
- Jacobs raised its fiscal 2026 outlook for the third consecutive quarter, targeting 9.5%–10% adjusted net
Progressive Q2 Earnings Call Highlights
Key Points
- Interested in The Progressive Corporation? Here are five stocks we like better.
- Progressive is targeting bundled auto-and-home households, known internally as “Robinsons,” which
Wall Street Analysts Think Methanex (MEOH) Could Surge 30.92%: Read This Before Placing a Bet
Methanex (MEOH) closed the last trading session at $53.53, gaining 16.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts Believe Napco (NSSC) Could Rally 25.14%: Here's is How to Trade
Shares of Napco (NSSC) have gained 4.7% over the past four weeks to close the last trading session at $40.22, but there could still be a solid upside left in the stock if short-term price targets of
Does Cushman & Wakefield (CWK) Have the Potential to Rally 25.71% as Wall Street Analysts Expect?
Cushman & Wakefield (CWK) closed the last trading session at $14.08, gaining 2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts See a 29.75% Upside in Sony (SONY): Can the Stock Really Move This High?
Sony (SONY) closed the last trading session at $22.35, gaining 4.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
How Much Upside is Left in Cohu (COHU)? Wall Street Analysts Think 28.27%
Cohu (COHU) closed the last trading session at $52.84, gaining 3.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Predict a 54.26% Upside in Ameresco (AMRC): Here's What You Should Know
Ameresco (AMRC) closed the last trading session at $27.94, gaining 9.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Pfizer Q2 Earnings Call Highlights Non-COVID Growth and Cost Cuts
Pfizer Inc. PFE used its second-quarter 2026 earnings call to stress that stronger non-COVID products are offsetting a weak infection season as investment targets oncology and obesity.
Management
NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim Nears
Key Points
- Interested in NewAmsterdam Pharma Company N.V.? Here are five stocks we like better.
- PREVAIL is the key near-term catalyst: NewAmsterdam expects to reach its interim event target by
Recursion Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Recursion Pharmaceuticals, Inc.? Here are five stocks we like better.
- Recursion advanced its pipeline, moving its first neuroscience target from the Roche/Genentech
Techtarget
WKN: A0MRMK / Symbol: TTGT / Name: TechTarget / Stock / Software & IT Services / Small Cap /